
Bill DeVaul
individual
About
Bill DeVaul is a biotechnology legal executive serving as Chief Legal Officer of Cambrian Bio, a clinical-stage drug development company focused on therapeutics for age-related metabolic decline. He previously served as General Counsel, Chief Compliance Officer, and Corporate Secretary at Morphic Holding, and earlier held senior legal and intellectual-property roles at Evelo Biosciences and Cubist Pharmaceuticals. His background centers on biotech legal strategy, IPOs, financings, licensing, M&A, compliance, and intellectual property.
Areas of interest
longevitybiotechdrug developmentintellectual propertycorporate governancecompliancelicensingmergers and acquisitions